As of 2024-12-15, the Intrinsic Value of Hemogenyx Pharmaceuticals PLC (HEMO.L) is
-1.81 GBP. This HEMO.L valuation is based on the model Peter Lynch Fair Value.
With the current market price of 420.00 GBP, the upside of Hemogenyx Pharmaceuticals PLC is
-100.43%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.81 GBP
Intrinsic Value
HEMO.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-1.81 - -1.81 |
-1.81 |
-100.43% |
| DDM - Stable |
(2.27) - (6.79) |
(4.53) |
-101.1% |
| DDM - Multi |
(2.55) - (6.14) |
(3.62) |
-100.9% |
HEMO.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
6,027.81 |
| Beta |
0.26 |
| Outstanding shares (mil) |
14.35 |
| Enterprise Value (mil) |
6,028.95 |
| Market risk premium |
5.98% |
| Cost of Equity |
11.96% |
| Cost of Debt |
5.00% |
| WACC |
11.96% |